PAFAH1B3 and neoplasm: In addition, the reduction of PAFAH1B3 expression substantially impaired cellular survival, motility, aggressiveness and in vivo tumor xenograft growth of triple-negative breast cancer cells, which implied PAFAH1b3 is a critical metabolic driver of breast cancer (11).